HI homepage

Trending
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval
Does BMI affect AI's accuracy when assessing CT scans?
New GE HealthCare partnership expands access to prostate cancer imaging agent
Repetitive head impact in soccer players increases risk of brain damage, MRI shows
Expert panel develops new breast biopsy guidelines
Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Congress Senate Washington D.C. DC
Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services. 

lung cancer screening
Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.

Interventional radiologist radiology IR genicular artery embolization surgery. Images courtesy of the University of Chicago Medicine
New data highlight 'critical' need to raise awareness about interventional radiology offerings

The specialty has seen significant growth in recent years, but a new analysis suggests that IR knowledge is still relatively limited outside the U.S.

Siemens Healthineers booth sign at RSNA 2024. The company expects to spend about between $227-$340 million on tariff mitigation efforts.Photo by Dave Fornell
Tariffs not enough to make Siemens Healthineers move production or raise prices—yet

The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday. 
 

Lawyer dies after severe allergic reaction to contrast media.
ACR updates guidance for managing and preventing contrast media reactions

The new recommendations address discordance between the college and other organizations’ prior guidelines on the use of premedication.
Incidental findings evident in 70% of lung screening exams, but few reported

Despite this, consensus is lacking on whether radiologists should be required to report on findings that are not relevant to the exam. 

Doctor mask covid
PET imaging reveals long-term heart and lung damage from COVID-19

New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments. 

Philips Healthcare booth sign at HIMSS23. While Philips Healthcare reported a profitable first quarter for 2025, the impact of tariffs and mitigation efforts dominated the conversation in it Q1 earnings call May 6. Philips estimates the U.S.-China tariffs will have a $226 to $340 net impact on Philips in 2025, even after "substantial" tariff mitigation efforts that the company said will cost hundreds of millions of dollars, including moving manufacturing and supply chains.
Tariffs will cost Philips Healthcare up to $340M

U.S.-China tariffs will have a $226M to $340M net impact on its bottom line in 2025, even after substantial mitigation efforts, the imaging manufacturer estimates. 
 

Around the web

Radiology Business
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Cardiovascular Business
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Radiology Business
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.